Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Encompass Health Corporation (EHC) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY25 Guidance
February 6, 2025 4:21 PM ESTEncompass Health Corporation (NYSE: EHC) reported Q4 EPS of $1.17, $0.14 better than the analyst estimate of $1.03. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.
GUIDANCE:
Encompass Health Corporation sees FY2025 EPS of $4.67-$4.96, versus the consensus... More
